Main Content

Hectorol Study

Study title

Open label, randomized parallel group study to assess the safety and efficacy of Hectorol in pediatric patients with chronic kidney disease (CKD) stage 3 and 4 with secondary hyperparathyroidism not yet on dialysis

• Principal Investigator: Dr. Mehul Dixit

Purpose

This study is to evaluate the possible risks and effectiveness of an experimental drug in patients with secondary hyperparathyroidism not yet on dialysis.

Who can participate

Those eligible to participate in this study include:

• Patients ages 5-18 years with CKD stage 3 or 4 who are not on dialysis.

For more information

• Bronwyn Briseno, RN
  University of Mississippi Medical Center 
  2500 N. State St. 
  Jackson MS 39216 
  (601) 815-5180
• IRB Number: 2017-0258